Skip to main content

Assessment of ARIA Sufficiency: Zepbound (tirzepatide)

    Basic Details
    Approval Date
    Friday, November 3, 2023
    Original Posting Date
    Health Outcome(s)
    adverse pregnancy and fetal outcomes
    medullary thyroid carcinoma